Pharmacokinetics (pk) of Pertuzumab (p) with Trastuzumab (t) and Docetaxel (d) in Her2-positive First-line Metastatic Breast Cancer (mbc): Results From the Phase III Trial Cleopatra

J Cortes, S Swain, I Kudaba, M Hauschild, T Patel, E Grincuka, N Masuda, V McNally, J Visich, J Baselga

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)124-125
Number of pages2
JournalAnnals of Oncology
Issue numberSuppl.9
Publication statusPublished - Sept 2012
Externally publishedYes
Event37th Congress of the European Society for Medical Oncology (ESMO) - Vienna, Austria
Duration: 28 Sept 20122 Oct 2012

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this